Subtle Medical secured $33 million to accelerate its AI image enhancement solutions for radiology.
Key Details
- 1Subtle Medical raised $33 million in growth capital, bringing total funding to approximately $86 million.
- 2The funding was led by Morgan Stanley Expansion Capital, with participation from several new and existing investors.
- 3Subtle's AI solutions (SubtleHD(MR) for MRI, and SubtlePET for PET) speed up scan times while maintaining image quality.
- 4SubtlePET received FDA 510(k) clearance in May and can reduce PET scan times by up to 75%.
- 5The technology is deployed on about 1,300 scanners worldwide, across major institutions like Mount Sinai and RadNet.
Why It Matters
Expanded funding allows Subtle Medical to further develop and deploy its vendor-neutral AI solutions, enhancing efficiency and patient throughput across radiology departments globally. Rapid scan times and improved imaging quality are key benefits for healthcare providers adopting AI technologies.
Source
Radiology Business
Related News
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•AuntMinnie
AI Advances in Ultrasound Highlighted at AIUM 2026 Keynote
AI is increasingly enhancing ultrasound imaging, clinical workflows, and education, though challenges in trust and implementation remain.
•AuntMinnie
LLM AI Significantly Boosts MRI Accuracy For Less Experienced Readers
AI LLMs notably improve diagnostic accuracy for less experienced brain MRI readers, with diminishing benefits for experts.